Shares have risen sharply this year, reflecting solid business performance. Its pharma segment is experiencing exceptional growth and has a long runway for continued expansion. My valuation model ...

Asahi Kasei Pharma Corporation has announced plans to relocate its R&D hub from Izunokuni City, Shizuoka Prefecture (Ohito) ...

Bain Capital has agreed to acquire Mitsubishi Chemical Group’s pharmaceutical business for more than $3 billion, a deal that ...

LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company developing therapies to surmount current cancer drug resistance and immune ...

This story is part of Forbes’ coverage of India’s Richest 2025. See the full list here. Brothers Sudhir and Samir Mehta are riding the momentum of India’s ambition to become the world’s pharmacy. In ...

LYON, France--(BUSINESS WIRE)--Brenus Pharma, a biotech company specializing in the development of cancer vaccines, announces the completion of a $25 million Series A financing round. The round is led ...

ZURICH, Jan 14 (Reuters) - Bayer (BAYGn.DE), opens new tab will focus on paying down debt and not make any major acquisitions in the next two or three years, the head of the German company's ...

On a day when AbbVie revealed booming sales of Skyrizi and Rinvoq and another positive adjustment to its 2025 guidance, the company also is reportedly angling to bolster its long-term prospects by way ...

Pharma commercial operating models rely on clinically testing many compounds to approve a single blockbuster that recoups all investments. The challenge for drug development is that clinical efficacy ...

BRIDGEWATER, N.J., December 11, 2025--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc. (Cosette), a U.S.-based, fully integrated pharmaceutical company, confirms that on 9 December 2025 it served a ...

In his first public appearance as Incyte’s CEO, Bill Meury outlined his priorities for the company, which include taking a “fresh look” at the business’ R&D, operating expenses and capital allocation.

Real-time measurement is key when proving how marketing is actually driving results for stakeholders and patients.